Medicine and Surgery Department, Allergy and Clinical Immunology, University of Parma, Parma, Italy
Erminia Ridolo is currently working as a Professor in the Department of Allergy and Clinical Immunology. Erminia Ridolo's research interests includes Allergy, Inflamation, Innate Immunity. She is serving as an editorial member and reviewer of several international reputed journals. Erminia Ridolo has successfully completed her Administrative responsibilities. Erminia has authored of many research articles/books related to Immunology, Inflamation.
Short Communication
The Current State of Safety of Allergen Immunotherapy
Author(s): Cristoforo Incorvaia*, Francesco Pucciarini, Bruena L. Gritti, Alessandro Barone and Erminia Ridolo
Allergen Immunotherapy (AIT) is aimed at treating allergy by modifying the immunological response to allergens.
However, administration of the causative allergen by Subcutaneous Immunotherapy (SCIT) to a sensitized patient
may result in severe, and rarely fatal, systemic reactions. The identification of risk factors for anaphylaxis, especially
concomitant uncontrolled asthma, has led to a significant reduction, but not yet elimination, in fatalities. The
option of Sublingual Immunotherapy (SLIT) has been shown to be safer, with no fatalities reported thus far and
including rare episodes of anaphylaxis, but the fact that the treatment is self-administered by the patient requires
precautions and careful education. .. View more»